查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1472313

長讀定序市場：按應用、按方法、按產品、按最終用戶：2023-2032 年全球市場機會分析與產業預測

Long Read Sequencing Market By Application, By Technique (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing), By Product, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 395 Pages | 商品交期: 2-3個工作天內

價格

2022年長讀定序市場價值為7.2443億美元，預計到2032年將達到51.6341億美元，2023年至2032年的複合年成長率為21.7%。長讀長定序是一種基因組技術，與傳統方法相比，可以讀取更長的 DNA拉伸。我們採用單分子定序等創新技術來產生數千到數百萬個鹼基對的 DNA 序列。 Pacific Biosciences 和 Oxford Nanopore Technologies 等平台利用奈米孔定序等技術來延長讀長。長讀長定序有助於對複雜的基因組區域、重複序列和結構變異進行全面分析。應用包括從頭基因組組裝、闡明複雜的基因組結構、了解遺傳疾病和探索微生物多樣性。總體而言，長讀長定序透過提供詳細且準確的基因組資訊徹底改變了基因組研究。

長讀定序市場-IMG1

遺傳疾病和癌症盛行率的上升是長讀長定序技術需求增加的主要驅動力。遺傳疾病和癌症本質上是複雜的疾病，受到多種遺傳因素的影響，包括突變、結構變異和基因組重排。長讀長定序提供了全面分析整個基因組的能力，使研究人員和臨床醫生能夠更準確地識別與這些疾病相關的罕見和新穎的遺傳變異。例如，世界衛生組織 (WHO) 估計，全球每年約有 40 萬名幼兒受到癌症影響，更好地了解癌症的遺傳基礎並開發標靶治療非常重要，這凸顯了對先進基因組技術的迫切需求。透過深入了解疾病的遺傳機制，長讀長定序在推動舉措醫療計畫和改善遺傳性疾病和癌症患者的臨床結果方面發揮關鍵作用。

此外，隨著定序成本的降低以及各領域對基因組學重要性的認知不斷提高，對全面的基因組見解的需求也在增加。長讀長定序可以更深入地了解基因組結構和功能，使研究人員能夠發現複雜的遺傳變異，並更了解疾病、性狀和演化過程的遺傳基礎。因此，遺傳和癌症疾病數量的增加以及長讀長定序在疾病診斷中的廣泛應用可能會阻礙市場的成長。

然而，長讀長定序領域缺乏熟練的專業人員預計將阻礙市場成長。操作和解釋來自長讀長定序平台的資料需要分子生物學、生物資訊學和基因組學方面的專業知識。缺乏訓練有素的人員可能會限制長讀長定序技術的採用和利用，從而延遲其引入研究、臨床診斷和工業應用。

長讀長定序市場按應用、技術、產品、最終用戶和地區進行細分。依用途分為研究用及臨床用。依技術分類，可分為單分子即時定序（SMRT）、奈米孔定序和合成長讀長定序。依產品分為設備、消耗品、服務。設備部分進一步分為系統和軟體。按最終用戶分類，可分為學術和政府研究機構、製藥和生技公司、醫院和診所等。按地區分類，北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙、其他歐洲地區）、亞太地區（日本、中國、印度、澳洲、韓國、其他亞太地區） ），在亞太地區（巴西、中國、非洲、阿拉伯和南美洲其他地區）進行分析。

相關人員的主要利益

本報告定量分析了2022年至2032年長讀長定序市場的細分市場、當前趨勢、估計/趨勢和動態，並識別了長讀長定序市場的強大機會。

它提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。

波特的五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的業務決策並加強供應商和買家網路。

對長讀測序市場細分的詳細分析有助於識別市場機會。

每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。

市場參與企業定位有助於基準化分析，並提供對市場參與企業當前地位的清晰了解。

該報告包括對區域和全球長讀測序市場趨勢、主要企業、細分市場、應用細分和市場成長策略的分析。

可使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 關鍵投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 精準醫療需求不斷成長
      • 聯盟和聯合研究數量的增加
      • 主要企業加大藥物研發力度
    • 抑制因素
      • 初始投資和成本高
    • 機會
      • 增加技術進步

第4章長讀定序市場：依應用分類

  • 概述
  • 研究用途
  • 臨床應用

第5章長讀定序市場：依技術分類

  • 概述
  • 單分子即時 (SMRT) 定序
  • 奈米孔定序
  • 合成長讀定序

第6章長讀定序市場：依產品

  • 概述
  • 裝置
    • 長讀定序設備市場：依類型
  • 消耗品
  • 服務

第7章長讀定序市場：依最終使用者分類

  • 概述
  • 學術/政府研究院
  • 製藥和生物技術公司
  • 醫院/診所
  • 其他

第8章長讀定序市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第10章 公司簡介

  • Agilent Technologies, Inc.
  • BaseClear BV
  • Cantata Bio
  • Element Biosciences
  • FG Technologies
  • GrandOmics
  • Illumina, Inc.
  • MicrobesNG
  • Novogene co., ltd.
  • Oxford Nanopore Technologies plc.
  • PacBio
  • St Vincents Hospital Melbourne
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • BGI Genomics
  • CD Genomics
Product Code: A14421

The long read sequencing market was valued at $724.43 million in 2022 and is estimated to reach $5,163.41 million by 2032, exhibiting a CAGR of 21.7% from 2023 to 2032. Long read sequencing is a genomic technique that reads longer stretches of DNA compared to traditional methods. It employs innovative technologies like single-molecule sequencing to generate DNA sequences spanning thousands to millions of base pairs. Platforms such as Pacific Biosciences and Oxford Nanopore Technologies utilize techniques such as nanopore sequencing to achieve extended read lengths. Long read sequencing facilitates comprehensive analysis of complex genomic regions, repetitive sequences, and structural variations. Its applications include de novo genome assembly, resolving complex genomic structures, understanding genetic diseases, and exploring microbial diversity. Overall, long read sequencing revolutionizes genomic research by providing detailed and accurate genomic information.

Long Read Sequencing Market - IMG1

The rise in the prevalence of genetic disorders and cancer is indeed a significant driver for the increased demand for long read sequencing technologies. Genetic disorders and cancer are inherently complex diseases influenced by multiple genetic factors, including mutations, structural variations, and genomic rearrangements. Long read sequencing offers the ability to comprehensively analyze the entire genome, enabling researchers and clinicians to identify rare and novel genetic variants associated with these diseases more accurately. For instance, the World Health Organization (WHO) estimated that approximately 400,000 children develop cancer every year worldwide, emphasizing the urgent need for advanced genomic technologies to better understand the genetic basis of cancer and develop targeted therapies. By providing insights into the underlying genetic mechanisms of disease, long read sequencing plays a crucial role in advancing precision medicine initiatives and improving clinical outcomes for patients with genetic disorders and cancer.

In addition, with the decreasing cost of sequencing and increasing awareness of the importance of genomics in various domains, there's a growing demand for comprehensive genomic insights. Long read sequencing provides a deeper understanding of genomic structure and function, allowing researchers to uncover complex genetic variations and better understand the genetic basis of diseases, traits, and evolutionary processes. Thus, the rise in genetic and cancer disorders and the wide application of long read sequencing in the disease diagnosis is potentially diving the market growth.

However, the lack of skilled professionals in the field of long read sequencing is expected to hinder market growth. Operating and interpreting data from long read sequencing platforms require specialized expertise in molecular biology, bioinformatics, and genomics. The shortage of adequately trained personnel may limit the adoption and utilization of long read sequencing technologies, delaying their implementation in research, clinical diagnostics, and industrial applications.

The long read sequencing market is segmented on the basis of application, technique, product, end user, and region. By application, it is bifurcated into research application and clinical application. By technique, the market is categorized into single-molecule real-time sequencing (SMRT), nanopore sequencing and synthetic long read sequencing. On the basis of product, it is segmented into instruments, consumables, and services. The instrument segment is further classified into system and software. By end user, it is segregated into academic and government research institutes, pharmaceutical and biotechnological companies, hospitals and clinics, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global long read sequencing market are Agilent Technologies, Inc. BaseClear BV, Cantata Bio, FG Technologies, Grandomics, MicrobesNG, Novogene co., ltd., Oxford Nanopore Technologies, Pacific Biosciences Inc., CD Genomics, Danaher Corporation, BGI Genomics, St Vincent's Hospital Australia, Takara Holdings Inc., Thermo Fisher Scientific, Inc., Element Biosciences, and Illumina, Inc. Key players operating in the market have adopted product launch, acquisition, partnership and collaboration as their key strategy to expand their product portfolio.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2022 to 2032 to identify the prevailing long read sequencing market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • Research Applications
  • Clinical Applications

By Technique

  • Nanopore Sequencing
  • Synthetic Long Read Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing

By Product

  • Instruments
    • Type
    • System
    • Software
  • Consumables
  • Services

By End User

  • Academic and Government Research Institutes
  • Pharmaceutical and Biotech Companies
  • Hospitals and Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cantata Bio
    • Illumina, Inc.
    • Danaher Corporation
    • Element Biosciences
    • FG Technologies
    • MicrobesNG
    • Oxford Nanopore Technologies plc.
    • CD Genomics
    • BGI Genomics
    • St Vincents Hospital Melbourne
    • Agilent Technologies, Inc.
    • TAKARA HOLDINGS INC.
    • BaseClear B.V.
    • GrandOmics
    • Novogene co., ltd.
    • PacBio
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in demand for precision medicine
      • 3.4.1.2. Rise in number of partnership and collaboration
      • 3.4.1.3. The growing initiatives taken by the key players for drug discovery
    • 3.4.2. Restraints
      • 3.4.2.1. High Initial Investment and Cost
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in technological advancements

CHAPTER 4: LONG READ SEQUENCING MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Research Applications
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Clinical Applications
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: LONG READ SEQUENCING MARKET, BY TECHNIQUE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Single-Molecule Real-Time (SMRT) Sequencing
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Nanopore Sequencing
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Synthetic Long Read Sequencing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: LONG READ SEQUENCING MARKET, BY PRODUCT

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Instruments
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
    • 6.2.4. Instruments Long Read Sequencing Market by Type
  • 6.3. Consumables
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Services
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: LONG READ SEQUENCING MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Academic and Government Research Institutes
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Pharmaceutical and Biotech Companies
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Hospitals and Clinics
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Others
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country

CHAPTER 8: LONG READ SEQUENCING MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Application
    • 8.2.3. Market size and forecast, by Technique
    • 8.2.4. Market size and forecast, by Product
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Application
      • 8.2.6.1.2. Market size and forecast, by Technique
      • 8.2.6.1.3. Market size and forecast, by Product
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Application
      • 8.2.6.2.2. Market size and forecast, by Technique
      • 8.2.6.2.3. Market size and forecast, by Product
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Application
      • 8.2.6.3.2. Market size and forecast, by Technique
      • 8.2.6.3.3. Market size and forecast, by Product
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Application
    • 8.3.3. Market size and forecast, by Technique
    • 8.3.4. Market size and forecast, by Product
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Application
      • 8.3.6.1.2. Market size and forecast, by Technique
      • 8.3.6.1.3. Market size and forecast, by Product
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Application
      • 8.3.6.2.2. Market size and forecast, by Technique
      • 8.3.6.2.3. Market size and forecast, by Product
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Application
      • 8.3.6.3.2. Market size and forecast, by Technique
      • 8.3.6.3.3. Market size and forecast, by Product
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Application
      • 8.3.6.4.2. Market size and forecast, by Technique
      • 8.3.6.4.3. Market size and forecast, by Product
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Application
      • 8.3.6.5.2. Market size and forecast, by Technique
      • 8.3.6.5.3. Market size and forecast, by Product
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Application
      • 8.3.6.6.2. Market size and forecast, by Technique
      • 8.3.6.6.3. Market size and forecast, by Product
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Application
    • 8.4.3. Market size and forecast, by Technique
    • 8.4.4. Market size and forecast, by Product
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Application
      • 8.4.6.1.2. Market size and forecast, by Technique
      • 8.4.6.1.3. Market size and forecast, by Product
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Application
      • 8.4.6.2.2. Market size and forecast, by Technique
      • 8.4.6.2.3. Market size and forecast, by Product
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Application
      • 8.4.6.3.2. Market size and forecast, by Technique
      • 8.4.6.3.3. Market size and forecast, by Product
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Application
      • 8.4.6.4.2. Market size and forecast, by Technique
      • 8.4.6.4.3. Market size and forecast, by Product
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Application
      • 8.4.6.5.2. Market size and forecast, by Technique
      • 8.4.6.5.3. Market size and forecast, by Product
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Application
      • 8.4.6.6.2. Market size and forecast, by Technique
      • 8.4.6.6.3. Market size and forecast, by Product
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Application
    • 8.5.3. Market size and forecast, by Technique
    • 8.5.4. Market size and forecast, by Product
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Application
      • 8.5.6.1.2. Market size and forecast, by Technique
      • 8.5.6.1.3. Market size and forecast, by Product
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Application
      • 8.5.6.2.2. Market size and forecast, by Technique
      • 8.5.6.2.3. Market size and forecast, by Product
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Market size and forecast, by Application
      • 8.5.6.3.2. Market size and forecast, by Technique
      • 8.5.6.3.3. Market size and forecast, by Product
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Application
      • 8.5.6.4.2. Market size and forecast, by Technique
      • 8.5.6.4.3. Market size and forecast, by Product
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Agilent Technologies, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
  • 10.2. BaseClear B.V.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
  • 10.3. Cantata Bio
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. Element Biosciences
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. FG Technologies
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. GrandOmics
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Key strategic moves and developments
  • 10.7. Illumina, Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. MicrobesNG
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Novogene co., ltd.
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Key strategic moves and developments
  • 10.10. Oxford Nanopore Technologies plc.
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Key strategic moves and developments
  • 10.11. PacBio
    • 10.11.1. Company overview
    • 10.11.2. Key executives
    • 10.11.3. Company snapshot
    • 10.11.4. Operating business segments
    • 10.11.5. Product portfolio
    • 10.11.6. Business performance
    • 10.11.7. Key strategic moves and developments
  • 10.12. St Vincents Hospital Melbourne
    • 10.12.1. Company overview
    • 10.12.2. Key executives
    • 10.12.3. Company snapshot
    • 10.12.4. Operating business segments
    • 10.12.5. Product portfolio
  • 10.13. TAKARA HOLDINGS INC.
    • 10.13.1. Company overview
    • 10.13.2. Key executives
    • 10.13.3. Company snapshot
    • 10.13.4. Operating business segments
    • 10.13.5. Product portfolio
    • 10.13.6. Business performance
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company overview
    • 10.14.2. Key executives
    • 10.14.3. Company snapshot
    • 10.14.4. Operating business segments
    • 10.14.5. Product portfolio
    • 10.14.6. Business performance
  • 10.15. Danaher Corporation
    • 10.15.1. Company overview
    • 10.15.2. Key executives
    • 10.15.3. Company snapshot
    • 10.15.4. Operating business segments
    • 10.15.5. Product portfolio
    • 10.15.6. Business performance
  • 10.16. BGI Genomics
    • 10.16.1. Company overview
    • 10.16.2. Key executives
    • 10.16.3. Company snapshot
    • 10.16.4. Operating business segments
    • 10.16.5. Product portfolio
  • 10.17. CD Genomics
    • 10.17.1. Company overview
    • 10.17.2. Key executives
    • 10.17.3. Company snapshot
    • 10.17.4. Operating business segments
    • 10.17.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 02. LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 05. LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. LONG READ SEQUENCING MARKET FOR SYNTHETIC LONG READ SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 09. LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. LONG READ SEQUENCING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. LONG READ SEQUENCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. LONG READ SEQUENCING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 24. U.S. LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. U.S. LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 26. U.S. LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. U.S. LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. CANADA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. CANADA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 30. CANADA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. GERMANY LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. UK LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. UK LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 51. UK LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. UK LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. ITALY LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ITALY LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 55. ITALY LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ITALY LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. REST OF EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. JAPAN LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 72. JAPAN LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. JAPAN LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. CHINA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. CHINA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 76. CHINA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. CHINA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. INDIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. INDIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 80. INDIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. INDIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. AUSTRALIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. AUSTRALIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 84. AUSTRALIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. AUSTRALIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. LAMEA LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. BRAZIL LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 101. BRAZIL LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. BRAZIL LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 105. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 109. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 114. REST OF LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 115. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 116. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 117. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 118. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 119. BASECLEAR B.V.: KEY EXECUTIVES
  • TABLE 120. BASECLEAR B.V.: COMPANY SNAPSHOT
  • TABLE 121. BASECLEAR B.V.: SERVICE SEGMENTS
  • TABLE 122. BASECLEAR B.V.: PRODUCT PORTFOLIO
  • TABLE 123. CANTATA BIO: KEY EXECUTIVES
  • TABLE 124. CANTATA BIO: COMPANY SNAPSHOT
  • TABLE 125. CANTATA BIO: PRODUCT SEGMENTS
  • TABLE 126. CANTATA BIO: SERVICE SEGMENTS
  • TABLE 127. CANTATA BIO: PRODUCT PORTFOLIO
  • TABLE 128. CANTATA BIO: KEY STRATERGIES
  • TABLE 129. ELEMENT BIOSCIENCES: KEY EXECUTIVES
  • TABLE 130. ELEMENT BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 131. ELEMENT BIOSCIENCES: PRODUCT SEGMENTS
  • TABLE 132. ELEMENT BIOSCIENCES: PRODUCT PORTFOLIO
  • TABLE 133. ELEMENT BIOSCIENCES: KEY STRATERGIES
  • TABLE 134. FG TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 135. FG TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 136. FG TECHNOLOGIES: PRODUCT SEGMENTS
  • TABLE 137. FG TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 138. GRANDOMICS: KEY EXECUTIVES
  • TABLE 139. GRANDOMICS: COMPANY SNAPSHOT
  • TABLE 140. GRANDOMICS: PRODUCT SEGMENTS
  • TABLE 141. GRANDOMICS: PRODUCT PORTFOLIO
  • TABLE 142. GRANDOMICS: KEY STRATERGIES
  • TABLE 143. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 144. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 145. ILLUMINA, INC.: PRODUCT SEGMENTS
  • TABLE 146. ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 147. ILLUMINA, INC.: KEY STRATERGIES
  • TABLE 148. MICROBESNG: KEY EXECUTIVES
  • TABLE 149. MICROBESNG: COMPANY SNAPSHOT
  • TABLE 150. MICROBESNG: PRODUCT SEGMENTS
  • TABLE 151. MICROBESNG: PRODUCT PORTFOLIO
  • TABLE 152. NOVOGENE CO., LTD.: KEY EXECUTIVES
  • TABLE 153. NOVOGENE CO., LTD.: COMPANY SNAPSHOT
  • TABLE 154. NOVOGENE CO., LTD.: SERVICE SEGMENTS
  • TABLE 155. NOVOGENE CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 156. NOVOGENE CO., LTD.: KEY STRATERGIES
  • TABLE 157. OXFORD NANOPORE TECHNOLOGIES PLC.: KEY EXECUTIVES
  • TABLE 158. OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT
  • TABLE 159. OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT SEGMENTS
  • TABLE 160. OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT PORTFOLIO
  • TABLE 161. OXFORD NANOPORE TECHNOLOGIES PLC.: KEY STRATERGIES
  • TABLE 162. PACBIO: KEY EXECUTIVES
  • TABLE 163. PACBIO: COMPANY SNAPSHOT
  • TABLE 164. PACBIO: PRODUCT SEGMENTS
  • TABLE 165. PACBIO: PRODUCT PORTFOLIO
  • TABLE 166. PACBIO: KEY STRATERGIES
  • TABLE 167. ST VINCENTS HOSPITAL MELBOURNE: KEY EXECUTIVES
  • TABLE 168. ST VINCENTS HOSPITAL MELBOURNE: COMPANY SNAPSHOT
  • TABLE 169. ST VINCENTS HOSPITAL MELBOURNE: PRODUCT SEGMENTS
  • TABLE 170. ST VINCENTS HOSPITAL MELBOURNE: PRODUCT PORTFOLIO
  • TABLE 171. TAKARA HOLDINGS INC.: KEY EXECUTIVES
  • TABLE 172. TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
  • TABLE 173. TAKARA HOLDINGS INC.: PRODUCT SEGMENTS
  • TABLE 174. TAKARA HOLDINGS INC.: PRODUCT PORTFOLIO
  • TABLE 175. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 176. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 177. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 178. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 179. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 180. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 181. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 182. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 183. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 184. BGI GENOMICS: KEY EXECUTIVES
  • TABLE 185. BGI GENOMICS: COMPANY SNAPSHOT
  • TABLE 186. BGI GENOMICS: SERVICE SEGMENTS
  • TABLE 187. BGI GENOMICS: PRODUCT PORTFOLIO
  • TABLE 188. CD GENOMICS: KEY EXECUTIVES
  • TABLE 189. CD GENOMICS: COMPANY SNAPSHOT
  • TABLE 190. CD GENOMICS: PRODUCT SEGMENTS
  • TABLE 191. CD GENOMICS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. LONG READ SEQUENCING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF LONG READ SEQUENCING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN LONG READ SEQUENCING MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN LONG READ SEQUENCING MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. LONG READ SEQUENCING MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SYNTHETIC LONG READ SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. LONG READ SEQUENCING MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. LONG READ SEQUENCING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. LONG READ SEQUENCING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 28. U.S. LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CANADA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. MEXICO LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. GERMANY LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. FRANCE LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. UK LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. ITALY LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SPAIN LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF EUROPE LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. JAPAN LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. CHINA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. INDIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH KOREA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. BRAZIL LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SAUDI ARABIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SOUTH AFRICA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF LAMEA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR (2020-2024)
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2024)
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY (2020-2024)
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: LONG READ SEQUENCING MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022
  • FIGURE 54. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 55. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 56. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 57. ILLUMINA, INC.: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 58. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 59. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 60. PACBIO: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 61. PACBIO: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 62. TAKARA HOLDINGS INC.: SALES REVENUE, 2021-2023 ($MILLION)
  • FIGURE 63. TAKARA HOLDINGS INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 64. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 69. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)